Loading...
Loading...
The vibrant growth of Indian Pharma Industry and the recommendations from four key National Pharma associations made. The Ministry of Commerce & Industry, Govt. of India realized the need for separate export promotion council for Pharma sector.
Vipan has more than 12 years of working experiences and guiding the team in the strategic Development and preparation of ESG reports. He is having a vast experiences of working in the field of Environment in legal, statutory, regulatory, environment compliance management and expertise in waste management. He is a Founder and MD of Corpseed. He is the one, who has developed World First Technology Driven AI Based Automated Compliance Model for All Businesses. He has worked with the Multinational Companies, such as Suncorp (Australian Bank), British Petroleum (UK), Eco- lab health care (USA), BHL, PGCL, UN-Group, SRY oil and gas, L&T, EVS electronics Ltd, Amzette, Faber, NTPC, Muthoot Finance, Capgemini etc.
Related articles
New Drug Manufacturing and Clinical Trial Rules Updated in 2026: What You Should Know?
2026-03-13
CDSCO Releases New Guidelines for Compounding of Offences Under the Drugs and Cosmetics Act
2026-02-26
Regulation of Medical Device Pricing and Quality in India: Key Government Measures
2026-02-20
CDSCO Releases Risk Classification List for Oncology Medical Devices
2026-02-12
Government Notifies CGHS Drug Procurement Policy 2026
2026-01-24
Draft Medical Devices Rules Amendment 2025: Regulatory Changes in Registration, Labelling, and Compliance
2025-12-15
2026-03-13 • 0 views
2023-02-27
BIS Compulsory Registration Exemption for Highly Specialized Equipment
2026-03-11
.png&w=1536&q=75)
